Scinai Immunotherapeutics Streamlines Operations, Prioritizes NanoAb Platform and CDMO Growth
Scinai Immunotherapeutics refocuses its R&D portfolio after ending PC111 license, aiming to boost its NanoAb platform and CDMO business.
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Capital Milestones
Onco-Innovations Ltd. has strengthened its clinical foundation for its lead candidate ONC010 through manufacturing milestones, IND-enabling activities, and a recent funding arrangement, positioning th...
Roth Capital Partners Announces Extensive Investor Event Schedule Through June 2027
Roth Capital Partners will host and sponsor over a dozen investor events from September 2026 to June 2027, including seven ROTH-hosted conferences across key growth sectors.
Wearable Devices to Showcase Neural Sensing Technology for Physical AI and Humanoid Robotics at Tel Aviv Event
Wearable Devices Ltd. will demonstrate its AI-powered neural sensing layer for Physical AI and humanoid robotics at Physical AI 2026, highlighting technology that complements vision-based training dat...
Faraday Future to Showcase Robotics at Moody Capital Disruptive Growth & Life Sciences Conference
Faraday Future Intelligent Electric Inc. will present its latest robotics initiatives at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference, highlighting its strategy in Emb...
Frontieras North America Offers Domestic Energy Solution Amid Geopolitical Disruption
Frontieras North America is developing coal-to-fuel infrastructure to reduce U.S. reliance on imported oil, highlighted by recent Strait of Hormuz closure.
Cyabra to Present at Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Cyabra, an AI-powered narrative intelligence company, will be featured at the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference, highlighting its role in combating disinforma...
Musk and Zuckerberg Urge G20 to Boost Data Center Infrastructure for AI
Elon Musk and Mark Zuckerberg have called on G20 nations to accelerate data center expansion, a move that could shape global AI policies and impact companies like Core AI Holdings.
Laser Therapy Emerges as Promising Brain Cancer Treatment Option
Researchers at Washington University School of Medicine have advanced laser therapy for brain cancer, offering a less invasive alternative to surgery and improving patient outcomes.
Impala Platinum Boosts Dividends as PGM Prices Surge; Industry Watches Rivals
Impala Platinum's enhanced dividend payout highlights a rebound in PGM prices, prompting industry observers to anticipate how other producers like Platinum Group Metals will manage their earnings.
OS Animal Health Highlights Canine Cancer Immunotherapy at Moody Capital Life Sciences Conference
OS Animal Health, a subsidiary of OS Therapies, is showcasing its HER2-targeting immunotherapy for canine osteosarcoma at the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conferenc...
Quantum BioPharma Receives FDA Clearance for Phase 2 Trial of Lucid-MS, a First-in-Class Candidate for Multiple Sclerosis
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS marks a potential breakthrough in MS treatment by targeting myelin repair, offering hope for disease modification beyond symptom manag...
Ocumetics Begins Patient Recruitment for Group Two Clinical Study of Next-Generation Intraocular Lens
Ocumetics Technology Corp. has initiated patient recruitment for the Group Two human clinical study of its accommodating intraocular lens, moving beyond safety to evaluate vision performance with next...
Quantum BioPharma Receives FDA Clearance for Phase 2 Trial of First-in-Class MS Drug Candidate
Quantum BioPharma's FDA clearance for a phase 2 trial of Lucid-MS, a drug targeting myelin repair, marks a potential breakthrough in multiple sclerosis treatment, offering hope beyond symptom manageme...
NanoViricides Registers Phase II Ebola Trial for Oral Antiviral NV-387 in Democratic Republic of Congo
NanoViricides has registered its Phase II clinical trial for NV-387 Oral Gummies against Ebola in the Pan African Clinical Trials Registry, moving forward with dosing in the DRC amid ongoing outbreaks...
Datavault AI Sets Sept. 15 Launch for Three Data Exchange Platforms
Datavault AI Inc. announces the commercial launch of its IDE(R), NIL Vault, and APEX platforms on Sept. 15, marking a shift from development to revenue generation.
LaFleur Minerals Advances Toward Gold Production at Fully Permitted Beacon Mill
LaFleur Minerals is set to transition from mill recommissioning to gold production at its Beacon Gold Mill in Val-d'Or, Canada, leveraging nearby Swanson Gold Deposit to become a near-term producer in...
Nutriband Advances Trademark Protection for Abuse-Deterrent Fentanyl Patch
Nutriband received a USPTO Notice of Publication for trademarks related to its abuse-deterrent fentanyl patch, moving closer to full trademark protection and supporting its commercial potential.
Greenland Mines Sets Q4 Biotech Spin-Off as It Sharpens Focus on Critical Minerals
Greenland Mines announces a Q4 2026 spin-off of its biotech division, Nasdaq compliance approval, and a high-value assessment for its Sarfartoq rare earths project, underscoring its strategic pivot to...
tZERO to Power Archax Markets' US Expansion with Regulated Digital Securities Infrastructure
tZERO Group announces a correspondent clearing relationship with Archax Markets LLC, enabling the newly approved US broker-dealer to offer regulated digital securities trading and custody through tZER...
Quantum BioPharma Gains FDA Clearance for Phase 2 Multiple Sclerosis Trial of Lucid-MS
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin Phase 2 testing in multiple sclerosis patients, potentially offering a new approach to treating demye...
Quantum BioPharma Gains Spotlight After FDA Clearance for Lucid-MS Phase 2 Trial in Multiple Sclerosis
Quantum BioPharma's FDA clearance to initiate a Phase 2 trial of Lucid-MS for multiple sclerosis marks a significant step toward a novel therapy that targets demyelination, potentially shifting the tr...
Quantum BioPharma Gains FDA Clearance for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS marks a pivotal step toward a targeted therapy for multiple sclerosis, potentially shifting treatment away from broad immunosuppressio...
DataTurk.ai Study Ranks Home Service Training Providers Across Key Business Categories
A new study by DataTurk.ai compares six top home service training organizations, revealing that Nexstar Network excels in operational systems while Service Excellence leads in customer and people-focu...
Lahontan Gold Strengthens Management Team Ahead of Santa Fe Mine 2027 Production Restart
Lahontan Gold Corp. announces three key management additions to advance the Santa Fe Mine toward its planned 2027 production restart.
ADM Endeavors Selected for Two New City Uniform Contracts, Including One with a City of Over 1 Million Residents
ADM Endeavors' subsidiary has been selected for two municipal uniform contracts, one with a city of over 1 million residents, pending council approval, which could significantly expand its public-sect...
Metavesco's Epic Labor Reports 129% Revenue Surge in August 2026
Epic Labor, a subsidiary of Metavesco, saw August 2026 revenue increase 129% year-over-year, reaching $382,730 despite a shorter fiscal month.
Nevada Organic Phosphate Retains P&E Mining Consultants for Murdock Mountain Project
Nevada Organic Phosphate Inc. has engaged P&E Mining Consultants to provide independent technical support for its Murdock Mountain phosphate project, advancing its development and de-risking efforts.